spacer
home > white papers > Mauritius Island – An Emerging Centre for R&D in Biotechnology and the Life Sciences - CIDP (Centre International de Développement Pharmaceutique)
WHITE PAPERS
logo_CIDP_(Cente.jpg

CIDP (Centre International de Développement Pharmaceutique)

phone +230 401 2600
email info@cidp-cro.com
web http://www.cidp-cro.com/
email BioPark Mauritius, Socota Phoenicia, Sayed Hossen Road, Phoenix 73408, Mauritius

Mauritius Island – An Emerging Centre for R&D in Biotechnology and the Life Sciences

Mauritius, the tropical island situated in the Indian Ocean and known worldwide for its beautiful beaches, is also internationally recognised for its rule of law, and political and social stability. Over the past few years, the economy has been successfully transitioned from a monocrop to a diversified innovation-driven and knowledge-based economy, resting on agribusiness, export-oriented manufacturing, tourism, financial services, property development and real estate, ICT-BPO, the seafood industry, a free port, logistics and a nascent ocean economy. Emerging sectors such as healthcare and life sciences are presenting some niche areas for the taking, and the enabling environment is being put in place to make it happen - especially in the light of sustained growth within pharmaceutical, medical device, and clinical research.

Important international players are already in operation locally as the country has established the appropriate legal and regulatory frameworks based on international norms, for the development of a strong biomedical research sector.
Mauritius Island – An Emerging Centre for R&D in Biotechnology and the Life Sciences
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Takara Bio Enters into a License and Supply Agreement of RetroNectin® with BioNTech Cell & Gene Therapies GmbH

Kusatsu/Shiga, Japan – June 24, 2021 – Life Science Newswire – Takara Bio Inc. announces that it has entered into a License and Supply Agreement with BioNTech Cell & Gene Therapies GmbH ("BioNTech"), a BioNTech SE company (www.BioNTech.de), Germany, under which Takara Bio grants BioNTech a commercial license to use applicable patents relating to RetroNectin®.
More info >>


White Papers

Biosimilars In Emerging Markets: Is It A Level Playing Field?

PRA Health Sciences (PRA)

Governments, healthcare payers, and social and health reforms, combined with the increased incidence of conditions such as cancer and diabetes are paving the way for increased uptake of biologic medicines in emerging markets. However, expensive biologic medicines can be prohibitive to many patients, creating a high level of unmet clinical need. At its best, the global expansion of biosimilars can mean a robust and steady supply of existing and new drugs reaching far-flung patient populations, but localized biosimilar drug developments, especially in China and India, combined with a lack of robust pharmacovigilance systems, threaten to derail the industry by putting patient health at risk.
More info >>


Industry Events

Pharma Integrates 2021

16 November 2021, VIRTUAL CONFERENCE

Now in its tenth year, Pharma Integrates is a unique event bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement